Background: Most breast cancer patients require lumpectomy with axillary sentinel lymph
node biopsy (SLNB) or axillary lymph node dissection (ALND). The ACOSOG Z0011-trial …

Hypothesis Performance of sentinel node biopsy (SNB) instead of full axillary lymph node
dissection (ALND) by inexperienced surgeons will lead to understaging of some women with …

BACKGROUND: Sentinel lymph node (SLN) biopsy has been well‐established for axillary
lymph node staging for patients with breast cancer. For lymph node‐negative patients …

Purpose The objective of this review is to summarize the evidence demonstrating that the
sentinel lymph node (SLN) procedure is not only associated with significantly less morbidity …

BACKGROUND: Although sentinel lymph node (SLN) biopsy is widely accepted as a
minimally invasive method of nodal staging, failure to identify an SLN mandates a level I/II …

For the second time in three decades breast cancer surgery is in transition. The gold
standard of axillary node dissection (AND) for regional lymph node staging surgery …

Background Axillary status in invasive breast cancer, established by sentinel lymph node
biopsy (SLNB) or ultrasound-guided lymph node biopsy, is an important prognostic …

Background The objective of this study is to assess the oncologic safety of sentinel lymph
node biopsy (SLNB), especially with regard to the axillary recurrence (AR) rate, and to …

Context.—Axillary nodal status remains one of the most important prognostic indicators in
the management of breast cancer. Axillary node metastases are seen in fewer than half of …

The sentinel lymph node (SLN) is the first lymph node to receive lymphatic drainage from a
tumor. SLN biopsy has become a mainstay of breast cancer management and is used when …